In a nested cohort of 3,645 pregnant women at risk of hyperglycaemia within a GDM treatment RCT, PMOS (prevalence 17.1%) was linked to early GDM (aOR 1.37), adverse neonatal composite (aOR 1.28) and neonatal unit admission (aOR 1.32), independent of BMI and ethnicity.
Secondary analysisn = 3,645
Neven et al. Maternal and Neonatal Complications in Pregnant Women With Polyendocrine Metabolic Ovarian Syndrome: A Nested Prospective Cohort Study